IRIS UniCatt

Nero, Camilla
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.757
AS - Asia 1.666
EU - Europa 1.416
SA - Sud America 423
AF - Africa 49
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 2
Totale 5.319
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.669
SG - Singapore 768
IT - Italia 400
CN - Cina 375
BR - Brasile 342
SE - Svezia 239
DE - Germania 222
VN - Vietnam 122
IN - India 99
GB - Regno Unito 97
FR - Francia 82
IE - Irlanda 82
FI - Finlandia 69
HK - Hong Kong 67
ID - Indonesia 62
UA - Ucraina 55
RU - Federazione Russa 38
CA - Canada 36
NL - Olanda 36
BD - Bangladesh 31
KR - Corea 29
AR - Argentina 27
MX - Messico 27
PL - Polonia 19
AT - Austria 18
JP - Giappone 17
BE - Belgio 15
EC - Ecuador 14
ES - Italia 14
IQ - Iraq 14
TR - Turchia 13
ZA - Sudafrica 13
IR - Iran 11
MA - Marocco 10
PH - Filippine 8
CO - Colombia 7
PY - Paraguay 7
VE - Venezuela 7
CI - Costa d'Avorio 6
CZ - Repubblica Ceca 6
IL - Israele 6
PE - Perù 6
PK - Pakistan 6
SA - Arabia Saudita 6
CL - Cile 5
JO - Giordania 5
KG - Kirghizistan 5
HN - Honduras 4
JM - Giamaica 4
KE - Kenya 4
LT - Lituania 4
TT - Trinidad e Tobago 4
AE - Emirati Arabi Uniti 3
DO - Repubblica Dominicana 3
EG - Egitto 3
HU - Ungheria 3
KZ - Kazakistan 3
MY - Malesia 3
NG - Nigeria 3
NZ - Nuova Zelanda 3
PT - Portogallo 3
UY - Uruguay 3
UZ - Uzbekistan 3
AO - Angola 2
AU - Australia 2
AW - Aruba 2
BO - Bolivia 2
DZ - Algeria 2
GF - Guiana Francese 2
HR - Croazia 2
LB - Libano 2
MD - Moldavia 2
MN - Mongolia 2
NI - Nicaragua 2
RO - Romania 2
SN - Senegal 2
TN - Tunisia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AM - Armenia 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CH - Svizzera 1
CR - Costa Rica 1
DM - Dominica 1
GE - Georgia 1
GI - Gibilterra 1
GT - Guatemala 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LY - Libia 1
NO - Norvegia 1
PA - Panama 1
PR - Porto Rico 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SR - Suriname 1
SV - El Salvador 1
Totale 5.316
Salva come PNG Salva come JPEG
Città #
Singapore 371
Chandler 272
Ashburn 238
Rome 153
Beijing 82
New York 79
Dublin 78
Hefei 68
Hong Kong 66
Hyderabad 57
Los Angeles 57
Ann Arbor 54
Jakarta 52
Milan 50
Ho Chi Minh City 49
The Dalles 42
Columbus 41
Munich 41
San Mateo 40
Dallas 35
Helsinki 35
São Paulo 33
Hanoi 32
Wilmington 30
Boston 29
Frankfurt am Main 29
Jacksonville 27
Seoul 23
Moscow 22
Nanjing 22
Princeton 20
Cattolica 19
Kent 19
Marseille 18
Dearborn 17
London 15
Rio de Janeiro 15
Bari 14
Brooklyn 14
Houston 14
Turku 14
Vienna 14
Atlanta 13
Boardman 13
Brussels 13
Buffalo 13
Nuremberg 12
Stockholm 12
Tokyo 12
Warsaw 12
Bexley 11
Fairfield 11
Lawrence 11
Nürnberg 11
Phoenix 11
Santa Clara 11
Chicago 10
Montreal 10
Orem 10
Seattle 10
Denver 9
Johannesburg 9
Lappeenranta 9
Leawood 9
Mexico City 9
Toronto 9
Washington 9
Woodbridge 9
Brasília 8
North Bergen 8
Poplar 8
Redwood City 8
Amsterdam 7
Bremen 7
Düsseldorf 7
San Francisco 7
Vancouver 7
Abidjan 6
Baghdad 6
Campinas 6
Council Bluffs 6
Lauterbourg 6
Newark 6
Querétaro 6
Quito 6
Roubaix 6
Turin 6
Amman 5
Andover 5
Augusta 5
Dhaka 5
Fortaleza 5
Islington 5
Izmir 5
Madrid 5
Manchester 5
Mountain View 5
Naples 5
Salvador 5
Changsha 4
Totale 2.869
Salva come PNG Salva come JPEG
Nome #
Patient-derived organoids and high grade serous ovarian cancer: from disease modeling to personalized medicine 175
Laparoscopic surgical management of localized recurrent ovarian cancer: a single-institution experience. 163
A laparoscopic risk-adjusted model to predict major complications after primary debulking surgery in ovarian cancer: A single-institution assessment 153
Lung cancer multi-omics digital human avatars for integrating precision medicine into clinical practice: the LANTERN study 144
Privacy in Italian Clinical Reports: A NLP-Based Anonymization Approach 138
Laparoscopic surgical management of localized recurrent ovarian cancer: a single-institution experience 132
Back to the future: The impact of oestrogen receptor profile in the era of molecular endometrial cancer classification 127
Dual inhibition of CDK12 and CDK13 uncovers actionable vulnerabilities in patient-derived ovarian cancer organoids 126
Building a personalized medicine infrastructure for gynecological oncology patients in a high-volume hospital 117
Targeting the hallmarks of ovarian cancer: The big picture 114
Pathologic response to neoadjuvant chemotherapy in advanced ovarian cancer: utility of a scoring system to predict outcomes 114
Infiltrating T lymphocytes and programmed cell death protein-1/programmed death-ligand 1 expression in endometriosis-associated ovarian cancer 113
Epithelial ovarian cancer and brain metastases: might the BRCA status, PARP inhibitor administration, and surgical treatment impact the survival? 110
Impact of Comprehensive Genome Profiling on the Management of Advanced Non–Small Cell Lung Cancer: Preliminary Results From the Lung Cancer Cohort of the FPG500 Program 110
Deep-Learning to Predict BRCA Mutation and Survival from Digital H&E Slides of Epithelial Ovarian Cancer 110
One-Step Nucleic Acid Amplification (OSNA): A fast molecular test based on CK19 mRNA concentration for assessment of lymph-nodes metastases in early stage endometrial cancer 108
Pd-l1 expression on circulating tumour-derived microvesicles as a complementary tool for stratification of high-grade serous ovarian cancer patients 107
Robotic Radical Hysterectomy After Concomitant Chemoradiation in Locally Advanced Cervical Cancer: A Prospective Phase II Study 106
Emerging role of immune checkpoint inhibitors in the treatment of ovarian cancer 102
Integrating a Comprehensive Cancer Genome Profiling into Clinical Practice: A Blueprint in an Italian Referral Center 101
Laparoscopic Management of a Small Bowel Recurrence of Endometrial Cancer 101
The immunohistochemical molecular risk classification in endometrial cancer: A pragmatic and high-reproducibility method 101
Assessment of preoperative nutritional status using BIA-derived phase angle (PhA) in patients with advanced ovarian cancer: Correlation with the extent of cytoreduction and complications 98
Benefit from maintenance with PARP inhibitor in newly diagnosed ovarian cancer according to BRCA1/2 mutation type and site: a multicenter real-world study 96
Recent progress in the use of pharmacotherapy for endometrial cancer 95
Characterization of shared neoantigens landscape in Mismatch Repair Deficient Endometrial Cancer 95
Integrating clinical-molecular data to predict PARP inhibitors efficacy in advanced ovarian cancer patients after interval cytoreductive surgery 94
Secondary Laparoscopic Cytoreduction in Recurrent Ovarian Cancer: A Large, Single-Institution Experience 93
Laparoscopic Radical Hysterectomy After Concomitant Chemoradiation in Locally Advanced Cervical Cancer: A Prospective Phase II Study 91
Sentinel-node biopsy in apparent early stage ovarian cancer: final results of a prospective multicentre study (SELLY) 90
Mesenteric lymph node involvement in advanced ovarian cancer patients undergoing rectosigmoid resection: Prognostic role and clinical considerations 90
Advanced and recurrent endometrial cancer: State of the art and future perspectives 89
A cost-effectiveness analysis of an integrated clinical-radiogenomic screening program for the identification of BRCA 1/2 carriers (e-PROBE study 89
Radiomics analysis of ultrasound images to discriminate between benign and malignant adnexal masses with solid morphology on ultrasound 87
PARP Inhibitors Resistance: Mechanisms and Perspectives 86
Oregovomab: an investigational agent for the treatment of advanced ovarian cancer 86
Germline BRCA 1-2 status prediction through ovarian ultrasound images radiogenomics: a hypothesis generating study (PROBE study) 81
Systematic Review of Cytoreductive Surgery and Bevacizumab-Containing Chemotherapy in Advanced Ovarian Cancer: Focus on Safety 78
Sentinel-node biopsy in early-stage ovarian cancer: preliminary results of a prospective multicentre study (SELLY) 77
Further refining 2020 ESGO/ESTRO/ESP molecular risk classes in patients with early-stage endometrial cancer: A propensity score–matched analysis 75
Correction: Lung cancer multi-omics digital human avatars for integrating precision medicine into clinical practice: the LANTERN study 75
Preclinical and Clinical Evidence of Lurbinectedin in Ovarian Cancer: Current Status and Future Perspectives 74
Are all mismatch repair deficient endometrial cancers created equal? A large, retrospective, tertiary center experience 74
Robotic Splenectomy for Isolated Splenic Recurrence of Endometrial Adenocarcinoma 74
Newly diagnosed ovarian cancer: Which first-line treatment? 74
Laparotomy approach to sentinel lymph node detection in ovarian cancer using a near-infrared fluorescent system camera with indocyanine green dye 73
Radiomics and Radiogenomics of Ovarian Cancer: Implications for Treatment Monitoring and Clinical Management 68
L1CAM Expression in Microcystic, Elongated, and Fragmented (MELF) Glands Predicts Lymph Node Involvement in Endometrial Carcinoma 67
Sentinel-node biopsy in early stage ovarian cancer: a prospective multicentre study (SELLY) 66
Minilaparoscopic Aortic Lymphadenectomy 62
Ovarian cancer patients with localized relapse: Clinical outcome and prognostic factors 61
Management of stage III and IVa uterine cancer 58
Laparoscopic Splenectomy for Secondary Cytoreduction in Ovarian Cancer Patients With Localized Spleen Recurrence: Feasibility and Technique 57
Verification of the prognostic precision of the new 2023 FIGO staging system in endometrial cancer patients - An international pooled analysis of three ESGO accredited centres 55
Timing and Pattern of Recurrence in Ovarian Cancer Patients with High Tumor Dissemination Treated with Primary Debulking Surgery Versus Neoadjuvant Chemotherapy 54
Mesenteric Lymph Node Involvement in Advanced Ovarian Cancer Patients Undergoing Rectosigmoid Resection: Prognostic Role and Clinical Considerations 50
Back to the future: The impact of oestrogen receptor profile in the era of molecular endometrial cancer classification 43
A fully virtual and nationwide molecular tumor board for gynecologic cancer patients: the virtual experience of the MITO cooperative group 25
Circulating tumor DNA in endometrial cancer: clinical significance and implications 18
Image-guided real-time optical biopsy in oncologic surgery: a systematic review of the role of confocal microscopy in the era of digital surgery 15
Circulating tumor DNA as a biomarker for predicting progression-free survival and overall survival in patients with epithelial ovarian cancer: a systematic review and meta-analysis 11
Totale 5.416
Salva come PNG Salva come JPEG
Categoria #
all - tutte 23.962
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.962
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202182 0 0 0 0 0 8 9 5 14 10 29 7
2021/2022312 12 13 4 24 18 5 15 55 15 27 49 75
2022/2023737 93 96 52 115 37 91 34 53 74 16 32 44
2023/2024523 12 116 23 47 26 57 43 33 5 30 65 66
2024/20251.350 39 28 96 60 91 63 63 50 153 168 311 228
2025/20261.977 391 225 224 420 562 155 0 0 0 0 0 0
Totale 5.416